Amlin Rating Reiterated by HSBC (AML)
Amlin (LON:AML)‘s stock had its “underweight” rating restated by analysts at HSBC in a research report issued to clients and investors on Tuesday, American Banking and Market News reports. They currently have a GBX 415 ($6.81) target price on the stock. HSBC’s price target suggests a potential downside of 4.73% from the stock’s previous close.
Amlin (LON:AML) opened at 429.00 on Tuesday. Amlin has a one year low of GBX 368.70 and a one year high of GBX 463.50. The stock’s 50-day moving average is GBX 439.1 and its 200-day moving average is GBX 418.2. The company’s market cap is £2.141 billion.
AML has been the subject of a number of other recent research reports. Analysts at Espirito Santo Investment Bank Research reiterated a “buy” rating on shares of Amlin in a research note to investors on Thursday, January 16th. They now have a GBX 509 ($8.36) price target on the stock. Separately, analysts at Westhouse Securities reiterated an “add” rating on shares of Amlin in a research note to investors on Thursday, January 16th. Finally, analysts at Credit Suisse reiterated an “underperform” rating on shares of Amlin in a research note to investors on Wednesday, January 15th. They now have a GBX 386 ($6.34) price target on the stock. Six investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company. Amlin has an average rating of “Hold” and an average target price of GBX 432.19 ($7.09).
Amlin plc is engaged in non-life insurance and reinsurance underwriting in the Lloyd’s market, Bermuda and Continental Europe.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.